Clinical Trials Logo

Clinical Trial Summary

To test the safety and efficacy of titrated oral misoprostol compared to vaginal dinoprostone for labor induction.


Clinical Trial Description

- There are many indications for induction of labor in the obstetric practice, of which prolonged gestational age stands as the most common indication. It is well recognized that with an unripe cervix, induction may be difficult and often unsuccessful. The use of an agent to ripen the cervix prior to induction is acceptable in the modern practice.

- Misoprostol, a prostaglandin E1 analogue, is the most interesting alternative to Dinoprostone because of its effectiveness, low cost, and temperature stability. It ripens the cervix by inducing regular uterine contractions. However, it is associated with several adverse effects especially uterine hyperstimulation, which is painful and may result in fetal compromise.

- Testing the efficacy and safety of titrated oral misoprostol versus vaginal dinoprostone may develop a new safe and effective method for labor induction. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Medical Induction of Labor Affecting Fetus

NCT number NCT02036437
Study type Interventional
Source Ain Shams University
Contact
Status Recruiting
Phase Phase 3
Start date September 2013
Completion date September 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02508402 - Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour Phase 4